IL6 and pneumonia: Tocilizumab (TCZ), an interleukin-6 (IL-6) receptor humanized monoclonal antibody, is therefore recommended by the Novel Coronavirus Diagnosis and Treatment of Pneumonia guidelines by the National Health Commission of China for severely ill patients with elevated IL-6.